Add to ORKGHere we report the effect of Onabotulinumtoxin-A (Onabot-A) in twelve patients with chronic migraine (CM=15 or more headaches/months), behaviourally, i.e. improvement in the headaches quantity/severity, and functionally, i.e. changes in brain functional connectivity (FC) patterns using resting-state-functional magnetic resonance imaging (rsfMRI)
Abstract Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerab...
Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible eff...
Migraine is a highly prevalent and disabling disorder accounted among the primary headaches. It is t...
Chronic migraine is a burdensome disease presenting with episodic pain and several symptoms that may...
The aim of this study was to identify structural and functional brain changes that accompanied the t...
Neck disability and pain are frequently encountered problems in patients with chronic migraine (CM)....
Background: Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the ...
Objective: The findings of resting-state functional MRI studies have suggested that abnormal functio...
WOS: 000365428100008Introduction: Resistant chronic migraine (RCM) causes a considerable decline in ...
Chronic migraine is a debilitating neurobiological disorder that affects approximately 1.4–2.2% of t...
OnabotulinumtoxinA is one of the main preventive treatments for chronic migraine. Despite that up to...
OnabotulinumtoxinA (BT-A) is one of the few drugs approved for the preventive treatment of chronic m...
Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. ...
Onabotulintoxin A (BontA) is an efficacious preventive treatment for chronic migraine, though the sp...
The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emergi...
Abstract Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerab...
Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible eff...
Migraine is a highly prevalent and disabling disorder accounted among the primary headaches. It is t...
Chronic migraine is a burdensome disease presenting with episodic pain and several symptoms that may...
The aim of this study was to identify structural and functional brain changes that accompanied the t...
Neck disability and pain are frequently encountered problems in patients with chronic migraine (CM)....
Background: Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the ...
Objective: The findings of resting-state functional MRI studies have suggested that abnormal functio...
WOS: 000365428100008Introduction: Resistant chronic migraine (RCM) causes a considerable decline in ...
Chronic migraine is a debilitating neurobiological disorder that affects approximately 1.4–2.2% of t...
OnabotulinumtoxinA is one of the main preventive treatments for chronic migraine. Despite that up to...
OnabotulinumtoxinA (BT-A) is one of the few drugs approved for the preventive treatment of chronic m...
Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. ...
Onabotulintoxin A (BontA) is an efficacious preventive treatment for chronic migraine, though the sp...
The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emergi...
Abstract Introduction The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerab...
Onabotulinumtoxin A (OBT-A) is a treatment option for chronic migraine (CM), though the possible eff...
Migraine is a highly prevalent and disabling disorder accounted among the primary headaches. It is t...